| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | pantothenate kinase activity | 2.24e-06 | 4 | 166 | 3 | GO:0004594 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC46A2 SLC25A21 SLC5A10 SLC25A14 SLC35A1 SLC5A7 SLC35D1 SLC2A10 SLC38A2 SLC39A12 SLC24A4 ABCD4 ATP2A1 ATP2A2 ATP2A3 SLC6A14 | 2.47e-06 | 477 | 166 | 16 | GO:0022804 |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 5.57e-06 | 5 | 166 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC46A2 SLC25A21 SLC5A10 SLC25A14 SLC35A1 SLC5A7 SLC35D1 SLC2A10 SLC38A2 SLC39A12 SLC24A4 SLC6A14 | 7.20e-06 | 296 | 166 | 12 | GO:0015291 |
| GeneOntologyMolecularFunction | symporter activity | SLC46A2 SLC5A10 SLC5A7 SLC2A10 SLC38A2 SLC39A12 SLC24A4 SLC6A14 | 3.73e-05 | 150 | 166 | 8 | GO:0015293 |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 8.86e-05 | 11 | 166 | 3 | GO:0005388 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | TENT4A PDGFRL RPS6KB1 RPS6KB2 PRAG1 MAP3K6 CIT PANK1 SIRT4 PARP6 PARP1 PANK2 CSNK1A1L MAST4 PI4KB PANK4 NT5C2 MAST1 MAP3K15 MAST3 | 1.06e-04 | 938 | 166 | 20 | GO:0016772 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP5ME SLC5A10 SLC25A14 SLC5A7 SLC40A1 SLC2A10 SLC38A2 SLC39A12 KCNT2 SLC24A4 P2RX7 CACNA1I ATP2A1 ATP2A2 ATP2A3 SLC6A14 | 1.38e-04 | 664 | 166 | 16 | GO:0008324 |
| GeneOntologyMolecularFunction | nucleotide-sugar transmembrane transporter activity | 1.92e-04 | 14 | 166 | 3 | GO:0005338 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC5A10 SLC5A7 SLC2A10 SLC38A2 SLC39A12 SLC24A4 ATP2A1 ATP2A2 ATP2A3 SLC6A14 | 2.19e-04 | 301 | 166 | 10 | GO:0022853 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ATP5ME SLC5A10 SLC25A14 SLC5A7 SLC40A1 SLC2A10 SLC38A2 SLC39A12 KCNT2 SLC24A4 CACNA1I ATP2A1 ATP2A2 ATP2A3 SLC6A14 | 2.43e-04 | 627 | 166 | 15 | GO:0022890 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | PDGFRL RPS6KB1 RPS6KB2 PRAG1 MAP3K6 CIT PANK1 PANK2 CSNK1A1L MAST4 PI4KB PANK4 NT5C2 MAST1 MAP3K15 MAST3 | 2.89e-04 | 709 | 166 | 16 | GO:0016773 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC46A2 ATP5ME SLC25A21 SLC5A10 SLC25A14 SLC35A1 SLC5A7 SLC40A1 SLC35D1 SLC2A10 SLC38A2 SLC39A12 KCNT2 SLC24A4 P2RX7 ABCD4 CACNA1I ATP2A1 ATP2A2 ATP2A3 SVOP SLC6A14 | 3.20e-04 | 1180 | 166 | 22 | GO:0022857 |
| GeneOntologyMolecularFunction | phosphatidylinositol-4-phosphate phosphatase activity | 4.08e-04 | 4 | 166 | 2 | GO:0043812 | |
| GeneOntologyMolecularFunction | calcium-dependent ATPase activity | 4.08e-04 | 4 | 166 | 2 | GO:0030899 | |
| GeneOntologyMolecularFunction | transporter activity | SLC46A2 ATP5ME SLC25A21 SLC5A10 SLC25A14 SLC35A1 SLC5A7 SLC40A1 SLC35D1 SLC2A10 SLC38A2 CLPTM1L SLC39A12 KCNT2 SLC24A4 P2RX7 ABCD4 CACNA1I ATP2A1 ATP2A2 ATP2A3 SVOP SLC6A14 | 4.31e-04 | 1289 | 166 | 23 | GO:0005215 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 4.82e-04 | 119 | 166 | 6 | GO:0015294 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC5A10 SLC5A7 SLC40A1 SLC38A2 SLC39A12 KCNT2 SLC24A4 CACNA1I ATP2A1 ATP2A2 ATP2A3 SLC6A14 | 5.29e-04 | 465 | 166 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | kinase activity | PDGFRL RPS6KB1 RPS6KB2 PRAG1 MAP3K6 CIT PANK1 PANK2 CSNK1A1L MAST4 PI4KB PANK4 NT5C2 MAST1 MAP3K15 MAST3 | 6.52e-04 | 764 | 166 | 16 | GO:0016301 |
| GeneOntologyMolecularFunction | NAD+-protein-aspartate ADP-ribosyltransferase activity | 6.76e-04 | 5 | 166 | 2 | GO:0140806 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC46A2 SLC25A21 SLC35A1 SLC35D1 SLC2A10 SLC38A2 SLC39A12 ABCD4 SLC6A14 | 7.93e-04 | 293 | 166 | 9 | GO:0008514 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ATP5ME SLC5A10 SLC25A14 SLC5A7 SLC40A1 SLC2A10 SLC38A2 SLC39A12 KCNT2 SLC24A4 P2RX7 CACNA1I ATP2A1 ATP2A2 ATP2A3 SLC6A14 | 9.67e-04 | 793 | 166 | 16 | GO:0015075 |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity | 1.01e-03 | 6 | 166 | 2 | GO:0043813 | |
| GeneOntologyMolecularFunction | NAD+-protein-cysteine ADP-ribosyltransferase activity | 1.01e-03 | 6 | 166 | 2 | GO:0140803 | |
| GeneOntologyMolecularFunction | pentosyltransferase activity | 1.21e-03 | 56 | 166 | 4 | GO:0016763 | |
| GeneOntologyMolecularFunction | NAD-dependent protein lysine deacetylase activity | 1.40e-03 | 7 | 166 | 2 | GO:0034979 | |
| GeneOntologyMolecularFunction | ribosomal protein S6 kinase activity | 1.40e-03 | 7 | 166 | 2 | GO:0004711 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 1.47e-03 | 59 | 166 | 4 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 1.47e-03 | 59 | 166 | 4 | GO:0015932 | |
| GeneOntologyMolecularFunction | NAD+-protein poly-ADP-ribosyltransferase activity | 1.59e-03 | 28 | 166 | 3 | GO:0003950 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP5ME SLC5A10 SLC25A14 SLC5A7 SLC40A1 SLC2A10 SLC38A2 SLC39A12 KCNT2 SLC24A4 CACNA1I ATP2A1 ATP2A2 ATP2A3 SLC6A14 | 1.68e-03 | 758 | 166 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | NAD+-protein ADP-ribosyltransferase activity | 1.94e-03 | 30 | 166 | 3 | GO:1990404 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity | 2.96e-03 | 10 | 166 | 2 | GO:0004439 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate 4-phosphatase activity | 2.96e-03 | 10 | 166 | 2 | GO:0034596 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.10e-03 | 171 | 166 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | NAD binding | 3.21e-03 | 73 | 166 | 4 | GO:0051287 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 3.29e-03 | 36 | 166 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 3.29e-03 | 36 | 166 | 3 | GO:0015662 | |
| GeneOntologyBiologicalProcess | Rap protein signal transduction | 3.90e-06 | 14 | 167 | 4 | GO:0032486 | |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 1.01e-05 | 36 | 167 | 5 | GO:0007274 | |
| GeneOntologyBiologicalProcess | calcium ion import into sarcoplasmic reticulum | 1.78e-05 | 7 | 167 | 3 | GO:1990036 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | FAT4 SDK2 RAP2B ZAN FAT3 RDX NLGN1 ADGRV1 KIRREL2 ITGA5 SVEP1 MSN CDH24 TENM4 NRXN2 DSG4 TNF HAS2 PCDHB1 CDH11 CNTN1 NCKAP1L | 6.01e-05 | 1077 | 167 | 22 | GO:0098609 |
| GeneOntologyBiologicalProcess | calcium ion transport from cytosol to endoplasmic reticulum | 6.52e-05 | 2 | 167 | 2 | GO:1903515 | |
| GeneOntologyBiologicalProcess | microvillus assembly | 7.29e-05 | 28 | 167 | 4 | GO:0030033 | |
| GeneOntologyBiologicalProcess | mitochondrial respirasome assembly | 8.20e-05 | 11 | 167 | 3 | GO:0097250 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum calcium ion homeostasis | 8.41e-05 | 29 | 167 | 4 | GO:0032469 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | HEXA RAP2A CPNE9 ZMPSTE24 FAT3 LAMA1 RDX NLGN1 PRAG1 CIT MSN WDR19 PARP6 RHOQ SLC39A12 CDH24 CSNK1A1L P2RX7 CDH11 PLXNA1 PLXNA2 CNTN1 NCKAP1L | 9.79e-05 | 1194 | 167 | 23 | GO:0000902 |
| GeneOntologyBiologicalProcess | establishment of endothelial barrier | 1.06e-04 | 58 | 167 | 5 | GO:0061028 | |
| GeneOntologyBiologicalProcess | coenzyme A biosynthetic process | 1.09e-04 | 12 | 167 | 3 | GO:0015937 | |
| GeneOntologyBiologicalProcess | microvillus organization | 1.59e-04 | 34 | 167 | 4 | GO:0032528 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 4.28e-05 | 9 | 170 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 8.31e-05 | 11 | 170 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | cell-cell junction | KLHL24 RAP2B LAMA1 RDX KIRREL2 ITGA5 LCP2 MSN CDH24 P2RX7 DSG4 RAP2C ATP2A2 CDH11 | 3.50e-04 | 591 | 170 | 14 | GO:0005911 |
| Domain | P-type_ATPase_IIA | 7.54e-07 | 3 | 171 | 3 | IPR005782 | |
| Domain | DUF1908 | 3.00e-06 | 4 | 171 | 3 | PF08926 | |
| Domain | LRRC37AB_C | 3.00e-06 | 4 | 171 | 3 | IPR029423 | |
| Domain | MA_Ser/Thr_Kinase_dom | 3.00e-06 | 4 | 171 | 3 | IPR015022 | |
| Domain | Type_II_PanK | 3.00e-06 | 4 | 171 | 3 | IPR004567 | |
| Domain | LRRC37AB_C | 3.00e-06 | 4 | 171 | 3 | PF14914 | |
| Domain | Fumble | 3.00e-06 | 4 | 171 | 3 | PF03630 | |
| Domain | LRRC37_N | 3.00e-06 | 4 | 171 | 3 | IPR032754 | |
| Domain | LRRC37 | 3.00e-06 | 4 | 171 | 3 | PF15779 | |
| Domain | MAST_pre-PK_dom | 3.00e-06 | 4 | 171 | 3 | IPR023142 | |
| Domain | LRRC37A/B-like | 3.00e-06 | 4 | 171 | 3 | IPR015753 | |
| Domain | - | 3.00e-06 | 4 | 171 | 3 | 1.20.1480.20 | |
| Domain | AGC-kinase_C | 1.20e-05 | 56 | 171 | 6 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 1.20e-05 | 56 | 171 | 6 | PS51285 | |
| Domain | S_TK_X | 1.20e-05 | 56 | 171 | 6 | SM00133 | |
| Domain | - | 2.68e-05 | 95 | 171 | 7 | 2.60.120.200 | |
| Domain | Pkinase_C | 3.92e-05 | 42 | 171 | 5 | PF00433 | |
| Domain | Ribosomal_S6_kinase | 8.33e-05 | 2 | 171 | 2 | IPR016238 | |
| Domain | Hydrolase_3 | 8.63e-05 | 10 | 171 | 3 | PF08282 | |
| Domain | - | 1.18e-04 | 11 | 171 | 3 | 3.40.50.1220 | |
| Domain | DHS-like_NAD/FAD-binding_dom | 1.56e-04 | 12 | 171 | 3 | IPR029035 | |
| Domain | Laminin_G | 1.88e-04 | 58 | 171 | 5 | IPR001791 | |
| Domain | ConA-like_dom | 1.92e-04 | 219 | 171 | 9 | IPR013320 | |
| Domain | DUF4071 | 2.49e-04 | 3 | 171 | 2 | PF13281 | |
| Domain | DUF4071 | 2.49e-04 | 3 | 171 | 2 | IPR025136 | |
| Domain | EGF | 3.23e-04 | 235 | 171 | 9 | SM00181 | |
| Domain | ATPase_P-typ_TM_dom | 3.87e-04 | 16 | 171 | 3 | IPR023298 | |
| Domain | - | 3.87e-04 | 16 | 171 | 3 | 1.20.1110.10 | |
| Domain | LAM_G_DOMAIN | 3.93e-04 | 38 | 171 | 4 | PS50025 | |
| Domain | ATPase_P-typ_cation-transptr_C | 4.67e-04 | 17 | 171 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 4.67e-04 | 17 | 171 | 3 | PF00689 | |
| Domain | Laminin_G_2 | 4.79e-04 | 40 | 171 | 4 | PF02210 | |
| Domain | EGF-like_dom | 4.92e-04 | 249 | 171 | 9 | IPR000742 | |
| Domain | ERM_C_dom | 4.94e-04 | 4 | 171 | 2 | IPR011259 | |
| Domain | ERM | 4.94e-04 | 4 | 171 | 2 | PF00769 | |
| Domain | Cyt_c_oxidase_su7a | 4.94e-04 | 4 | 171 | 2 | IPR003177 | |
| Domain | ERM | 4.94e-04 | 4 | 171 | 2 | IPR011174 | |
| Domain | Cadherin_CS | 5.02e-04 | 109 | 171 | 6 | IPR020894 | |
| Domain | Cation_ATPase_N | 5.56e-04 | 18 | 171 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 5.56e-04 | 18 | 171 | 3 | SM00831 | |
| Domain | EGF_1 | 5.84e-04 | 255 | 171 | 9 | PS00022 | |
| Domain | CADHERIN_1 | 6.07e-04 | 113 | 171 | 6 | PS00232 | |
| Domain | Cadherin | 6.07e-04 | 113 | 171 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 6.36e-04 | 114 | 171 | 6 | PS50268 | |
| Domain | - | 6.36e-04 | 114 | 171 | 6 | 2.60.40.60 | |
| Domain | ATPase_P-typ_cation-transptr_N | 6.56e-04 | 19 | 171 | 3 | IPR004014 | |
| Domain | CA | 6.66e-04 | 115 | 171 | 6 | SM00112 | |
| Domain | EGF-like_CS | 6.90e-04 | 261 | 171 | 9 | IPR013032 | |
| Domain | LamG | 6.92e-04 | 44 | 171 | 4 | SM00282 | |
| Domain | Cadherin-like | 6.97e-04 | 116 | 171 | 6 | IPR015919 | |
| Domain | Cadherin | 7.63e-04 | 118 | 171 | 6 | IPR002126 | |
| Domain | EGF_2 | 7.69e-04 | 265 | 171 | 9 | PS01186 | |
| Domain | Syja_N | 8.18e-04 | 5 | 171 | 2 | PF02383 | |
| Domain | SAC | 8.18e-04 | 5 | 171 | 2 | PS50275 | |
| Domain | SAC_dom | 8.18e-04 | 5 | 171 | 2 | IPR002013 | |
| Domain | VWFA | 9.38e-04 | 82 | 171 | 5 | PS50234 | |
| Domain | VWA | 1.05e-03 | 84 | 171 | 5 | SM00327 | |
| Domain | - | 1.22e-03 | 6 | 171 | 2 | 2.40.50.90 | |
| Domain | Staphylococal_nuclease_OB-fold | 1.22e-03 | 6 | 171 | 2 | IPR016071 | |
| Domain | EGF_3 | 1.48e-03 | 235 | 171 | 8 | PS50026 | |
| Domain | Cadherin_C | 1.50e-03 | 25 | 171 | 3 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 1.50e-03 | 25 | 171 | 3 | IPR000233 | |
| Domain | SIR2 | 1.70e-03 | 7 | 171 | 2 | PF02146 | |
| Domain | Moesin_tail | 1.70e-03 | 7 | 171 | 2 | IPR008954 | |
| Domain | Ssirtuin_cat_dom | 1.70e-03 | 7 | 171 | 2 | IPR026590 | |
| Domain | Sirtuin | 1.70e-03 | 7 | 171 | 2 | IPR003000 | |
| Domain | SIRTUIN | 1.70e-03 | 7 | 171 | 2 | PS50305 | |
| Domain | S_TKc | RPS6KB1 RPS6KB2 PRAG1 MAP3K6 CIT CSNK1A1L MAST4 MAST1 MAP3K15 MAST3 | 1.78e-03 | 359 | 171 | 10 | SM00220 |
| Domain | - | 1.88e-03 | 27 | 171 | 3 | 2.130.10.80 | |
| Domain | VWF_A | 2.17e-03 | 99 | 171 | 5 | IPR002035 | |
| Domain | Catenin_binding_dom | 2.31e-03 | 29 | 171 | 3 | IPR027397 | |
| Domain | - | 2.31e-03 | 29 | 171 | 3 | 4.10.900.10 | |
| Domain | FN3 | 2.42e-03 | 199 | 171 | 7 | PS50853 | |
| Domain | Pkinase | RPS6KB1 RPS6KB2 PRAG1 MAP3K6 CIT CSNK1A1L MAST4 MAST1 MAP3K15 MAST3 | 2.74e-03 | 381 | 171 | 10 | PF00069 |
| Domain | Copine | 2.88e-03 | 9 | 171 | 2 | PF07002 | |
| Domain | Plexin_cytopl | 2.88e-03 | 9 | 171 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 2.88e-03 | 9 | 171 | 2 | IPR013548 | |
| Domain | Plexin | 2.88e-03 | 9 | 171 | 2 | IPR031148 | |
| Domain | Copine | 2.88e-03 | 9 | 171 | 2 | IPR010734 | |
| Domain | - | 3.08e-03 | 32 | 171 | 3 | 3.40.1110.10 | |
| Domain | - | 3.08e-03 | 32 | 171 | 3 | 2.70.150.10 | |
| Domain | FN3_dom | 3.18e-03 | 209 | 171 | 7 | IPR003961 | |
| Domain | FERM_N | 3.36e-03 | 33 | 171 | 3 | IPR018979 | |
| Domain | FERM_N | 3.36e-03 | 33 | 171 | 3 | PF09379 | |
| Domain | Gal_Oxidase_b-propeller | 3.66e-03 | 34 | 171 | 3 | IPR015916 | |
| Domain | RAS | 3.98e-03 | 35 | 171 | 3 | PS51421 | |
| Domain | ATPase_P-typ_cyto_domN | 3.98e-03 | 35 | 171 | 3 | IPR023299 | |
| Domain | TPR_REGION | 4.17e-03 | 165 | 171 | 6 | PS50293 | |
| Domain | TPR | 4.17e-03 | 165 | 171 | 6 | PS50005 | |
| Domain | ATPase_P-typ_P_site | 4.31e-03 | 36 | 171 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 4.31e-03 | 36 | 171 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 4.31e-03 | 36 | 171 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 4.66e-03 | 37 | 171 | 3 | IPR008250 | |
| Domain | Small_GTPase_Ras | 4.66e-03 | 37 | 171 | 3 | IPR020849 | |
| Domain | Pkinase_C | 4.66e-03 | 37 | 171 | 3 | IPR017892 | |
| Domain | E1-E2_ATPase | 4.66e-03 | 37 | 171 | 3 | PF00122 | |
| Domain | - | 4.74e-03 | 74 | 171 | 4 | 3.40.50.410 | |
| Domain | SSF | 5.18e-03 | 12 | 171 | 2 | PF00474 | |
| Domain | NA_SOLUT_SYMP_2 | 5.18e-03 | 12 | 171 | 2 | PS00457 | |
| Domain | Na/solute_symporter | 5.18e-03 | 12 | 171 | 2 | IPR001734 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA | 2.95e-05 | 8 | 116 | 3 | M47955 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 6.60e-05 | 27 | 116 | 4 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 7.65e-05 | 28 | 116 | 4 | M924 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.13e-04 | 12 | 116 | 3 | M27326 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC5A10 SLC35A1 SLC5A7 SLC40A1 SLC35D1 SLC2A10 SLC38A2 SLC24A4 SLC6A14 | 1.52e-04 | 238 | 116 | 9 | MM15076 |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 1.64e-04 | 99 | 116 | 6 | M27474 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.85e-04 | 14 | 116 | 3 | MM15052 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC5A10 SLC35A1 SLC5A7 SLC40A1 SLC35D1 SLC2A10 SLC38A2 SLC24A4 SLC6A14 | 2.14e-04 | 249 | 116 | 9 | M5988 |
| Pathway | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | 2.30e-04 | 15 | 116 | 3 | MM14782 | |
| Pathway | WP_NAD_METABOLISM | 2.81e-04 | 16 | 116 | 3 | M39541 | |
| Pathway | KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS | 2.81e-04 | 16 | 116 | 3 | M7528 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 4.05e-04 | 18 | 116 | 3 | M614 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.86e-04 | 121 | 116 | 6 | M872 | |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 1.91e-08 | 91 | 173 | 8 | 28558017 | |
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 16410239 | ||
| Pubmed | Rap2, but not Rap1 GTPase is expressed in human red blood cells and is involved in vesiculation. | 4.82e-07 | 4 | 173 | 3 | 16540189 | |
| Pubmed | 4.82e-07 | 4 | 173 | 3 | 21548202 | ||
| Pubmed | 4.82e-07 | 4 | 173 | 3 | 25110346 | ||
| Pubmed | The nongastric H+-K+-ATPases: molecular and functional properties. | 4.82e-07 | 4 | 173 | 3 | 10362770 | |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 4.82e-07 | 4 | 173 | 3 | 19091768 | |
| Pubmed | 4.82e-07 | 4 | 173 | 3 | 2981478 | ||
| Pubmed | 4.82e-07 | 4 | 173 | 3 | 22419166 | ||
| Pubmed | A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. | 4.82e-07 | 4 | 173 | 3 | 11479594 | |
| Pubmed | Ubiquitylation by Rab40b/Cul5 regulates Rap2 localization and activity during cell migration. | 1.20e-06 | 5 | 173 | 3 | 35293963 | |
| Pubmed | 1.20e-06 | 5 | 173 | 3 | 22891241 | ||
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 1.20e-06 | 5 | 173 | 3 | 17855024 | |
| Pubmed | Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1. | 4.17e-06 | 7 | 173 | 3 | 24786561 | |
| Pubmed | 4.17e-06 | 7 | 173 | 3 | 34708032 | ||
| Pubmed | FAT4 LRRC37A3 TNC MRPS27 NAP1L3 ITGA5 WDR19 SLC38A2 HIGD1A CLPTM1L PIGT PI4KB DSG4 TNF | 4.21e-06 | 638 | 173 | 14 | 31182584 | |
| Pubmed | Widespread control of calcium signaling by a family of SERCA-inhibiting micropeptides. | 6.65e-06 | 8 | 173 | 3 | 27923914 | |
| Pubmed | 6.65e-06 | 8 | 173 | 3 | 10951186 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 6.65e-06 | 8 | 173 | 3 | 19033399 | |
| Pubmed | A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. | 9.94e-06 | 9 | 173 | 3 | 25640239 | |
| Pubmed | Essential role for the Prader-Willi syndrome protein necdin in axonal outgrowth. | 1.41e-05 | 10 | 173 | 3 | 15649943 | |
| Pubmed | 1.41e-05 | 10 | 173 | 3 | 23064749 | ||
| Pubmed | 1.91e-05 | 32 | 173 | 4 | 26184908 | ||
| Pubmed | 2.15e-05 | 230 | 173 | 8 | 35449600 | ||
| Pubmed | GATA-6 is a novel transcriptional repressor of the human Tenascin-C gene expression in fibroblasts. | 2.46e-05 | 2 | 173 | 2 | 18177748 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 33003310 | ||
| Pubmed | Dystrophic muscle in mice chimeric for expression of alpha5 integrin. | 2.46e-05 | 2 | 173 | 2 | 9813102 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 27273097 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 17550782 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 19650915 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 11748357 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 15718407 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 9070278 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 9314546 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 23830920 | ||
| Pubmed | Mechanism of microglia neuroprotection: Involvement of P2X7, TNFα, and valproic acid. | 2.46e-05 | 2 | 173 | 2 | 26295445 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 25270119 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 27438654 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 18953100 | ||
| Pubmed | Tumor necrosis factor alpha drives cadherin 11 expression in rheumatoid inflammation. | 2.46e-05 | 2 | 173 | 2 | 18821672 | |
| Pubmed | SERCA overexpression reduces hydroxyl radical injury in murine myocardium. | 2.46e-05 | 2 | 173 | 2 | 16798816 | |
| Pubmed | A therapeutic approach to pantothenate kinase associated neurodegeneration. | 2.46e-05 | 2 | 173 | 2 | 30352999 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 21885870 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 11983108 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 10103110 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 9804755 | ||
| Pubmed | Plexin/neuropilin complexes mediate repulsion by the axonal guidance signal semaphorin 3A. | 2.46e-05 | 2 | 173 | 2 | 10781943 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 12556521 | ||
| Pubmed | Different interactomes for p70-S6K1 and p54-S6K2 revealed by proteomic analysis. | 2.46e-05 | 2 | 173 | 2 | 27493124 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 19644701 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 29453656 | ||
| Pubmed | Sarco(endo)plasmic reticulum Ca2+ ATPases (SERCA1 and -2) in human extraocular muscles. | 2.46e-05 | 2 | 173 | 2 | 14638697 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 18174371 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 16213650 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 9822608 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 19962989 | ||
| Pubmed | Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer. | 2.46e-05 | 2 | 173 | 2 | 20953835 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 17359518 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 22412899 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 11402072 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 8424780 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 18758466 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 20932932 | ||
| Pubmed | Sarco(endo)plasmic reticulum Ca2+ ATPase isoforms and their role in muscle physiology and pathology. | 2.46e-05 | 2 | 173 | 2 | 10603953 | |
| Pubmed | Characterizing SERCA Function in Murine Skeletal Muscles after 35-37 Days of Spaceflight. | 2.46e-05 | 2 | 173 | 2 | 34769190 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 18295663 | ||
| Pubmed | Gene amplification of ribosomal protein S6 kinase-1 and -2 in gastric cancer. | 2.46e-05 | 2 | 173 | 2 | 23393338 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 20080710 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 12529391 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 15060135 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 12975374 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 18846252 | ||
| Pubmed | Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity. | 2.57e-05 | 12 | 173 | 3 | 28406212 | |
| Pubmed | 2.57e-05 | 12 | 173 | 3 | 23342162 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 3.82e-05 | 38 | 173 | 4 | 30786075 | |
| Pubmed | FRMPD1 SMARCAD1 NLGN1 FEM1B TENM4 TBC1D1 NAV1 MAST1 PACS2 PLXNA2 | 4.04e-05 | 407 | 173 | 10 | 12693553 | |
| Pubmed | Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library. | 4.23e-05 | 14 | 173 | 3 | 17662146 | |
| Pubmed | Rap2A links intestinal cell polarity to brush border formation. | 5.27e-05 | 15 | 173 | 3 | 22797597 | |
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 8479753 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 18261459 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 19064715 | ||
| Pubmed | mTOR/S6 kinase pathway contributes to astrocyte survival during ischemia. | 7.36e-05 | 3 | 173 | 2 | 19535330 | |
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 21864676 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 14613898 | ||
| Pubmed | Inhibition of cell adhesion by phosphorylated Ezrin/Radixin/Moesin. | 7.36e-05 | 3 | 173 | 2 | 26555866 | |
| Pubmed | Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle. | 7.36e-05 | 3 | 173 | 2 | 27055500 | |
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 18006852 | ||
| Pubmed | Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation. | 7.36e-05 | 3 | 173 | 2 | 16889625 | |
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 17116882 | ||
| Pubmed | [Effect of erythropoietin on proinflammatory factors of human monocytes and its mechanisms]. | 7.36e-05 | 3 | 173 | 2 | 21729562 | |
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 9788433 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 16973504 | ||
| Pubmed | Effect of knockdown of ezrin, radixin, and moesin on P-glycoprotein function in HepG2 cells. | 7.36e-05 | 3 | 173 | 2 | 21837648 | |
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 27592202 | ||
| Pubmed | Activation of Ras requires the ERM-dependent link of actin to the plasma membrane. | 7.36e-05 | 3 | 173 | 2 | 22132106 | |
| Pubmed | Distinct Roles of mTOR Targets S6K1 and S6K2 in Breast Cancer. | 7.36e-05 | 3 | 173 | 2 | 32054043 | |
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 20817730 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 28283575 | ||
| Pubmed | Selective down-regulation of nuclear poly(ADP-ribose) glycohydrolase. | 7.36e-05 | 3 | 173 | 2 | 19319190 | |
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 20516213 | ||
| GeneFamily | Solute carriers | SLC46A2 SLC25A21 SLC5A10 SLC25A14 SLC35A1 SLC5A7 SLC40A1 SLC35D1 SLC2A10 SLC38A2 SLC39A12 SLC24A4 SLC6A14 | 1.68e-06 | 395 | 117 | 13 | 752 |
| GeneFamily | ATPases Ca2+ transporting | 2.16e-05 | 9 | 117 | 3 | 1209 | |
| GeneFamily | Sirtuins | 8.54e-04 | 7 | 117 | 2 | 938 | |
| GeneFamily | RAS type GTPase family | 1.04e-03 | 31 | 117 | 3 | 389 | |
| GeneFamily | Copines | 1.45e-03 | 9 | 117 | 2 | 829 | |
| GeneFamily | Plexins | 1.45e-03 | 9 | 117 | 2 | 683 | |
| GeneFamily | Kelch like|BTB domain containing | 2.52e-03 | 42 | 117 | 3 | 617 | |
| GeneFamily | CD molecules|Type II classical cadherins | 3.09e-03 | 13 | 117 | 2 | 1186 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.96e-03 | 161 | 117 | 5 | 593 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 4.15e-03 | 50 | 117 | 3 | 1293 | |
| GeneFamily | Cadherin related | 5.30e-03 | 17 | 117 | 2 | 24 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 5.30e-03 | 17 | 117 | 2 | 684 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 6.61e-03 | 19 | 117 | 2 | 131 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | FAT4 TNC GPX3 COL6A5 SYNDIG1 KCNT2 MAMDC2 CRYBG3 HAS2 CDH11 CNTN1 | 3.45e-10 | 198 | 172 | 11 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.87e-09 | 199 | 172 | 10 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.16e-09 | 200 | 172 | 10 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.16e-09 | 200 | 172 | 10 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.16e-09 | 200 | 172 | 10 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-08 | 181 | 172 | 9 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-08 | 181 | 172 | 9 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.00e-08 | 191 | 172 | 9 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.27e-08 | 192 | 172 | 9 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.27e-08 | 192 | 172 | 9 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 6.27e-08 | 192 | 172 | 9 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.86e-08 | 194 | 172 | 9 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.86e-08 | 194 | 172 | 9 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.86e-08 | 194 | 172 | 9 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.48e-08 | 196 | 172 | 9 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.48e-08 | 196 | 172 | 9 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.48e-08 | 196 | 172 | 9 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.82e-08 | 197 | 172 | 9 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.82e-08 | 197 | 172 | 9 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.16e-08 | 198 | 172 | 9 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-07 | 176 | 172 | 8 | 926ed37e636fe4dd3a18731cea15761f0c2c285a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.19e-07 | 188 | 172 | 8 | e18065bbc26d6f3774fd1f478fb41d8fb555fa26 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.48e-07 | 189 | 172 | 8 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.79e-07 | 190 | 172 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.79e-07 | 190 | 172 | 8 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.10e-07 | 191 | 172 | 8 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.10e-07 | 191 | 172 | 8 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.43e-07 | 192 | 172 | 8 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 8.76e-07 | 193 | 172 | 8 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 8.76e-07 | 193 | 172 | 8 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.11e-07 | 194 | 172 | 8 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 9.11e-07 | 194 | 172 | 8 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.11e-07 | 194 | 172 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.47e-07 | 195 | 172 | 8 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.47e-07 | 195 | 172 | 8 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.47e-07 | 195 | 172 | 8 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.47e-07 | 195 | 172 | 8 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.47e-07 | 195 | 172 | 8 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | -Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 9.47e-07 | 195 | 172 | 8 | e5b0afbea85575851cf9eb50a9ac42c67bbf3d7c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.84e-07 | 196 | 172 | 8 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-06 | 197 | 172 | 8 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-06 | 197 | 172 | 8 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-06 | 197 | 172 | 8 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-06 | 198 | 172 | 8 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.06e-06 | 198 | 172 | 8 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.06e-06 | 198 | 172 | 8 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.06e-06 | 198 | 172 | 8 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.10e-06 | 199 | 172 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.10e-06 | 199 | 172 | 8 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.10e-06 | 199 | 172 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.10e-06 | 199 | 172 | 8 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-06 | 199 | 172 | 8 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.10e-06 | 199 | 172 | 8 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-06 | 199 | 172 | 8 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-06 | 199 | 172 | 8 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-06 | 199 | 172 | 8 | 212e89d097753790061310373a1fafba773488b6 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.10e-06 | 199 | 172 | 8 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-06 | 199 | 172 | 8 | 14b676aa289c0578a37be32cec3ea285c79d97cc | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.14e-06 | 200 | 172 | 8 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-06 | 200 | 172 | 8 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-06 | 200 | 172 | 8 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-06 | 200 | 172 | 8 | cb31cfcfa8e6d6cc610c4c22e97bc009dd8a9e7c | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-06 | 200 | 172 | 8 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-06 | 200 | 172 | 8 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 2.89e-06 | 159 | 172 | 7 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 3.55e-06 | 164 | 172 | 7 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-06 | 169 | 172 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-06 | 172 | 172 | 7 | f6b4754a7e4b3e38030316a0ae00d932bfa87e41 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.24e-06 | 174 | 172 | 7 | 7d4b860e05b5931f6f9d757a68f75ff35597a47a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.44e-06 | 175 | 172 | 7 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-06 | 175 | 172 | 7 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.86e-06 | 177 | 172 | 7 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.86e-06 | 177 | 172 | 7 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.54e-06 | 180 | 172 | 7 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.54e-06 | 180 | 172 | 7 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-06 | 180 | 172 | 7 | 12537d8a569faa69f474284d2c201475722b8ca1 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.54e-06 | 180 | 172 | 7 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-06 | 181 | 172 | 7 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.78e-06 | 181 | 172 | 7 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.29e-06 | 183 | 172 | 7 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.29e-06 | 183 | 172 | 7 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.29e-06 | 183 | 172 | 7 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.55e-06 | 184 | 172 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.55e-06 | 184 | 172 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.55e-06 | 184 | 172 | 7 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.55e-06 | 184 | 172 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.82e-06 | 185 | 172 | 7 | 8fc357ee041bfd588986730a52ea2021b5f88941 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-06 | 186 | 172 | 7 | ca5e9c6531cb5d199e27509bfab1d62e3937177e | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-06 | 186 | 172 | 7 | 1ed71b229f40a680071b14f5a7a19706e0fd14b1 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-06 | 186 | 172 | 7 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.10e-06 | 186 | 172 | 7 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.10e-06 | 186 | 172 | 7 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.39e-06 | 187 | 172 | 7 | f1d0fc625e0e7881b3f290742fd7148d995eb71e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.39e-06 | 187 | 172 | 7 | 02e7246ef5ad41773d14426254e139b156d45c1d | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.39e-06 | 187 | 172 | 7 | 08c73d125e0638c9e9878165bba2442c266c8a48 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 8.39e-06 | 187 | 172 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.39e-06 | 187 | 172 | 7 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.69e-06 | 188 | 172 | 7 | f3edcefeef2ce19086032d98b243c02a6d542b38 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.69e-06 | 188 | 172 | 7 | 0792432cd4c564dea1102241ea9884f7ced7658c | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 8.99e-06 | 189 | 172 | 7 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| Drug | periodate-oxidized adenosine 5'-triphosphate | 1.60e-06 | 4 | 169 | 3 | ctd:C004282 | |
| Drug | D-pantothenoyl-L-cysteine | 1.60e-06 | 4 | 169 | 3 | CID000440217 | |
| Drug | AC1NSKPI | 4.06e-06 | 57 | 169 | 6 | CID005311482 | |
| Disease | Brody myopathy (implicated_via_orthology) | 1.69e-07 | 3 | 164 | 3 | DOID:0050692 (implicated_via_orthology) | |
| Disease | pantothenate kinase-associated neurodegeneration (implicated_via_orthology) | 6.72e-07 | 4 | 164 | 3 | DOID:3981 (implicated_via_orthology) | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 2.08e-06 | 105 | 164 | 7 | DOID:9352 (implicated_via_orthology) | |
| Disease | platelet-derived growth factor receptor-like protein measurement | 9.18e-05 | 3 | 164 | 2 | EFO_0801889 | |
| Disease | Malignant neoplasm of breast | RPS6KB2 FRMPD1 LRRC37A2 MANEA MAP3K6 SLC2A10 CLPTM1L PARP1 SLC39A12 NAA25 NLRP14 LRRC37A KCNT2 TNF FASTKD3 ATP2A3 ENPEP | 1.07e-04 | 1074 | 164 | 17 | C0006142 |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 1.29e-04 | 18 | 164 | 3 | EFO_0006831, EFO_0006896 | |
| Disease | Stunned Myocardium | 1.83e-04 | 4 | 164 | 2 | C0206145 | |
| Disease | Myocardial Stunning | 1.83e-04 | 4 | 164 | 2 | C0206146 | |
| Disease | Hibernation, Myocardial | 1.83e-04 | 4 | 164 | 2 | C0376416 | |
| Disease | epilepsy (implicated_via_orthology) | 3.11e-04 | 163 | 164 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | response to antiviral drug, cirrhosis of liver | 3.13e-04 | 24 | 164 | 3 | EFO_0001422, EFO_0010123 | |
| Disease | amphetamine abuse (implicated_via_orthology) | 4.54e-04 | 6 | 164 | 2 | DOID:670 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | PDGFRL RPS6KB1 LAMA1 HAT1 PARP1 CSNK1A1L P2RX7 PANK4 ABCD4 TNF MUTYH CNTN1 | 5.86e-04 | 702 | 164 | 12 | C0009402 |
| Disease | Parkinsonism, Juvenile | 6.13e-04 | 30 | 164 | 3 | C0752105 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 6.13e-04 | 30 | 164 | 3 | EFO_0000341, EFO_0004351 | |
| Disease | perinatal necrotizing enterocolitis (is_marker_for) | 6.33e-04 | 7 | 164 | 2 | DOID:8677 (is_marker_for) | |
| Disease | Anemia | 8.89e-04 | 34 | 164 | 3 | C0002871 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.05e-03 | 80 | 164 | 4 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Asthma | 1.05e-03 | 80 | 164 | 4 | C0004096 | |
| Disease | Recurrent depression | 1.08e-03 | 9 | 164 | 2 | C0221480 | |
| Disease | alcohol dependence (implicated_via_orthology) | 1.08e-03 | 9 | 164 | 2 | DOID:0050741 (implicated_via_orthology) | |
| Disease | heart disease (implicated_via_orthology) | 1.23e-03 | 38 | 164 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | thalamus volume | 1.31e-03 | 85 | 164 | 4 | EFO_0006935 | |
| Disease | Ceroid lipofuscinosis, neuronal 1, infantile | 1.34e-03 | 10 | 164 | 2 | C2931673 | |
| Disease | congestive heart failure (implicated_via_orthology) | 1.54e-03 | 41 | 164 | 3 | DOID:6000 (implicated_via_orthology) | |
| Disease | hippocampal CA4 volume | 1.54e-03 | 41 | 164 | 3 | EFO_0009396 | |
| Disease | Diabetic Cardiomyopathies | 1.63e-03 | 11 | 164 | 2 | C0853897 | |
| Disease | Premature Birth | 1.63e-03 | 11 | 164 | 2 | C0151526 | |
| Disease | nevus count, cutaneous melanoma | 1.69e-03 | 91 | 164 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 1.83e-03 | 93 | 164 | 4 | DOID:3525 (biomarker_via_orthology) | |
| Disease | Hereditary hemochromatosis | 1.95e-03 | 12 | 164 | 2 | C0392514 | |
| Disease | stomach carcinoma (is_implicated_in) | 1.95e-03 | 12 | 164 | 2 | DOID:5517 (is_implicated_in) | |
| Disease | Hemochromatosis | 1.95e-03 | 12 | 164 | 2 | C0018995 | |
| Disease | chronic kidney disease | 2.07e-03 | 235 | 164 | 6 | EFO_0003884 | |
| Disease | smoking status measurement, ulcerative colitis | 2.30e-03 | 13 | 164 | 2 | EFO_0000729, EFO_0006527 | |
| Disease | Mood Disorders | 2.53e-03 | 168 | 164 | 5 | C0525045 | |
| Disease | oral cavity cancer | 2.67e-03 | 14 | 164 | 2 | EFO_0005570 | |
| Disease | vision disorder | 3.50e-03 | 16 | 164 | 2 | MONDO_0021084 | |
| Disease | Intellectual Disability | 3.66e-03 | 447 | 164 | 8 | C3714756 | |
| Disease | cortical thickness | KLHL24 FAT3 LAMA1 COX7A2 COX7A2P2 SMARCAD1 ADGRV1 MAST4 PMPCA RALGPS1 NAV1 CDH11 PLXNA2 SOS2 | 3.81e-03 | 1113 | 164 | 14 | EFO_0004840 |
| Disease | thrombomodulin measurement | 3.95e-03 | 17 | 164 | 2 | EFO_0007774 | |
| Disease | cytochrome-c oxidase deficiency disease (implicated_via_orthology) | 3.95e-03 | 17 | 164 | 2 | DOID:3762 (implicated_via_orthology) | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 3.95e-03 | 17 | 164 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | ankle injury | 4.36e-03 | 59 | 164 | 3 | EFO_1002021 | |
| Disease | triacylglycerol 56:3 measurement | 4.43e-03 | 18 | 164 | 2 | EFO_0010430 | |
| Disease | progression free survival, ovarian carcinoma | 4.43e-03 | 18 | 164 | 2 | EFO_0001075, EFO_0004920 | |
| Disease | Cleft palate, cleft lip | 4.81e-03 | 279 | 164 | 6 | EFO_0003959, HP_0000175 | |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 4.93e-03 | 19 | 164 | 2 | EFO_0002609, GO_0031427 | |
| Disease | cutaneous melanoma, hair color | 5.01e-03 | 62 | 164 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | pulmonary hypertension (is_marker_for) | 5.48e-03 | 64 | 164 | 3 | DOID:6432 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TTLGLLYLQLGIYQK | 206 | Q96RK4 | |
| KLGANVYTLGVADYN | 201 | A6NF34 | |
| YYGNLGIVPSSIIKF | 316 | Q86XM0 | |
| YLSDQLVLDVKGGNY | 2931 | Q68DQ2 | |
| YGNLLKVDAYGNLLV | 106 | P49902 | |
| GVYLSLYTRVAINGK | 246 | P59827 | |
| GKYVLFVNVASYUGL | 61 | P22352 | |
| LYISSIIGTITNGLY | 36 | Q49SQ1 | |
| LTGLGTAVQLYSAYE | 3741 | Q6V0I7 | |
| ILLNSTGDTVVYQYG | 1091 | Q8WXG9 | |
| YKGEGLNKTAIGTYL | 101 | Q9UIA0 | |
| LTVGGTAYAIYELAV | 61 | P14406 | |
| YIGINTFDYLGSILS | 271 | O14678 | |
| VIALLSLGIAYYVSG | 201 | Q86W74 | |
| LTVGGTAYAIYQLAV | 61 | O60397 | |
| GAIYLASSYQDKLRV | 1881 | O14578 | |
| GAIYYFKIAVALAVA | 291 | O14983 | |
| GAVYYFKIAVALAVA | 291 | Q93084 | |
| LATGAGAIYLLYKAI | 21 | Q5T9G4 | |
| VSLALGQAGYVVYKS | 471 | Q9UF12 | |
| NYGSTVKINSRGLVY | 546 | Q8NFF2 | |
| YIKNGQGFILVYSLV | 71 | P10114 | |
| YIKNGQGFILVYSLV | 71 | P61225 | |
| YIKNGQGFILVYSLV | 71 | Q9Y3L5 | |
| ILSGSTLLYYGAKSL | 461 | Q5JS13 | |
| VQVTGYAVYADGLKV | 1121 | A6NNM3 | |
| VQVTGYAVYADGLKV | 1121 | A6NJZ7 | |
| GFAAIVAYGLYKLKS | 36 | Q9Y241 | |
| TLGLVDIVKGTNSYY | 556 | P09874 | |
| VFAYISINSGNGKLY | 501 | Q9Y5F3 | |
| SVVSLFYGAILGVYL | 246 | Q15622 | |
| TTGLGYYLLANTKFT | 376 | Q7Z304 | |
| TAVLLASYAVQAKYG | 121 | P35241 | |
| TLYLTGGALLAAAAY | 66 | Q5TGI0 | |
| TVYQEEGILALYKGL | 256 | Q9BQT8 | |
| GASYIGLKAVVDFLY | 91 | Q8N4N3 | |
| LATVIAYAYTGKLTL | 121 | Q9H511 | |
| YGYTKKLILALIVTG | 1576 | O60309 | |
| AYIIINKLGYHTGNL | 1086 | Q9UJ55 | |
| YGYTDKLILALIVTG | 1576 | A6NM11 | |
| YGYTDKLILALIVTG | 1576 | A6NMS7 | |
| ATLAIGSSRGKIYQY | 261 | Q8NHV4 | |
| AGITVGILLSYALNY | 141 | O95528 | |
| GILLSYALNYALAGT | 146 | O95528 | |
| SKYIINGIYTAEILA | 456 | Q86SJ6 | |
| GYVYKAASEGKVLTL | 6 | Q9UK73 | |
| SYGNSAKLVYTVLDG | 181 | Q86UP0 | |
| VRYLGSASQGGYLKI | 706 | O95382 | |
| GEVYVGAVNRIYKLS | 61 | Q9UIW2 | |
| AVYVGAINRVYKLTG | 61 | O75051 | |
| DVYINKVYGILGAFI | 196 | A6NMU1 | |
| GTSFLQLLISYGYIV | 211 | Q8NGJ0 | |
| QLLISYGYIVSAVLK | 216 | Q8NGJ0 | |
| SGLYYNGLKVLALAA | 1311 | Q9P2S2 | |
| LAGVKAYIGFIQSLA | 741 | P55160 | |
| VDLIYAFQTGGKLYL | 156 | P23443 | |
| AFQTGGKLYLILEYL | 161 | P23443 | |
| TAVLLASYAVQSKYG | 121 | P26038 | |
| YGLASVKNVTLLSRY | 821 | Q07075 | |
| QLLYESKLYTILQGG | 56 | Q8N752 | |
| LFETILLGYLSYKGN | 116 | Q6UVM3 | |
| LYDGSVLASYGNVIV | 231 | Q8N2Q7 | |
| IIAIGAGIILGYSYK | 181 | Q96FE7 | |
| YKNRTILGYKTLAAG | 121 | Q86VP3 | |
| YAIAGLIFLEYKASA | 181 | A2RRP1 | |
| RINGKYYEIGLSAAL | 376 | Q5SRI9 | |
| TIKLISNGAYGAVYL | 376 | Q9Y2H9 | |
| ENKASTYGLNYLLSG | 171 | Q5XG87 | |
| YIQLVAGSYIIGSIN | 141 | Q8NH89 | |
| IGGSLTKLAYYSTVQ | 41 | Q9NVE7 | |
| GSGVSILAVYSKDNY | 391 | Q9BZ23 | |
| GLYYNGLKVLALAAE | 266 | P58401 | |
| GYVTILNGSDIRSLY | 301 | P08648 | |
| IQLVVYIGSTLSYFG | 331 | Q99572 | |
| KYSGQDGLYIGVSLA | 561 | Q92908 | |
| GAIYYFKIAVALAVA | 291 | P16615 | |
| GLKILLYYIAGSLST | 71 | O14929 | |
| NNLIYVAGGLTKAIY | 501 | Q6TFL4 | |
| GKCALAYQLYSLGLI | 501 | Q92562 | |
| ESYIALLVGAKYGIS | 411 | Q5SYB0 | |
| LKVVSLGLYFGEQAY | 1221 | Q9P0X4 | |
| TGGTYTGKALDYILQ | 516 | A8TX70 | |
| GKASQYYILLILTDG | 506 | Q9UBL6 | |
| IAVGLVRAYLAKGSY | 56 | Q6Y1H2 | |
| AAKISDGSQYYVLLI | 416 | Q8IYJ1 | |
| TYGAIYANAELKILA | 396 | Q12860 | |
| KGENGYITYSIASLN | 501 | Q8TDW7 | |
| SLLLGITAAYIVGYQ | 21 | Q92819 | |
| ILHKQTSGYIVYGLF | 316 | Q6K0P9 | |
| YGNSAKLVYSILEGQ | 191 | P55287 | |
| ALTGYLKSNLNTYGE | 231 | Q7Z388 | |
| YLLVSKGGYFSVNLN | 156 | Q6P1S2 | |
| KLISNGAYGAVYLVR | 371 | O60307 | |
| ETIKLISNGAYGAVY | 571 | O15021 | |
| IFKGYNATVLAYGQT | 76 | Q2VIQ3 | |
| NGYYKVRGVSVSLSL | 601 | Q6UWL6 | |
| VSSLLLYIIKIGGDY | 181 | O75844 | |
| GGITALIAAAKYPSY | 141 | Q86WA6 | |
| AQLTGLGKYVLYEVQ | 1261 | Q58EX2 | |
| KYGYSTVAVTLLTLG | 366 | Q504Y0 | |
| LGLSLTIIAYKDGYV | 131 | Q6P995 | |
| AAYGKGIYLSPISSI | 501 | Q2NL67 | |
| GSGVSILAVYSKDNY | 416 | Q8TE04 | |
| TYYGLILQAEKNGAT | 291 | Q6ZUA9 | |
| IQTLLDIVSSYGKGY | 356 | P06865 | |
| QYLGSVSENGYIKIF | 711 | Q6ZN16 | |
| GTGKTYLTNRLAEYL | 1561 | Q8NEY1 | |
| NLTKIVAYLGTYIGG | 736 | Q13423 | |
| SSNSYFLGGVLIVLY | 326 | Q96EX2 | |
| FSSQLYGYALLGKVE | 221 | Q92552 | |
| IATLYTLVGGLYSVA | 171 | Q9GZV3 | |
| GILINSGSRYEAKYL | 91 | Q10713 | |
| GGLYTSVVVKYTDNI | 256 | P78382 | |
| YAVSVTVGGKQYLLG | 46 | P17081 | |
| TVGGKQYLLGLYDTA | 51 | P17081 | |
| YYGLVLLTTELFQAG | 331 | Q8N4V2 | |
| VYVVNKAGGLIYQLD | 6 | Q9Y296 | |
| YISADILKLAGNYVF | 136 | Q07890 | |
| YYAVAVVKKGGSFQL | 111 | P02788 | |
| LGKTIQAIAFLAYLY | 526 | Q9H4L7 | |
| YVGVAVALIAYLSKN | 241 | Q9H7V2 | |
| GTYSKVLDAYGLLGV | 51 | O43426 | |
| IVELAYAFQTGGKLY | 131 | Q9UBS0 | |
| VQVTGYAVYADGLKV | 1121 | Q9UFD9 | |
| LYRYVKIGLTNLLGA | 536 | Q14CZ7 | |
| DIEYILIKASYGQGL | 1316 | P25391 | |
| LSEGYGQLCSIYLKL | 131 | O00291 | |
| IYLLGKVYVANAGDS | 266 | Q5JR12 | |
| LLVVGSSLQVYSGYR | 256 | Q9Y6E7 | |
| VELYGNSLLLTAVYG | 51 | Q9NP59 | |
| IKLTYQVYGLALEGQ | 446 | Q9UIF7 | |
| VILKSIYYYTGEVNG | 476 | Q99457 | |
| GNYLAVTGADYIVKI | 26 | Q8NEZ3 | |
| VRNAKYLVVYTGAGI | 96 | Q9NRC8 | |
| GLNISIAGSLVYSYI | 316 | Q9NTN3 | |
| GGRSQISVKYQLLYV | 251 | Q15198 | |
| TTKLYDGFQYLTNGI | 801 | Q9UBF8 | |
| INNGKYILSGLTYLS | 1911 | Q4LDE5 | |
| LGGLRTALYNYIFAK | 51 | Q5JPH6 | |
| LSLKGYGFQITAYFL | 76 | Q5VYV7 | |
| IKLGRYSALFLGVAY | 11 | P56385 | |
| LCVGGAVYSLLNIKY | 411 | Q96KA5 | |
| SNYVLQLAGVGSYLK | 286 | Q9NPF2 | |
| QLVKEGLASYEIGYI | 856 | Q9BXT8 | |
| GLASYEIGYILKDNS | 861 | Q9BXT8 | |
| LLRQASYGTIKIGIY | 111 | O95258 | |
| NASVGDKVLYGLYGI | 721 | Q70EL2 | |
| YGLQKGELSTLLYNT | 361 | Q969N2 | |
| ALYTIAGGLAAVIYT | 181 | A0PJK1 | |
| SLLYEQLGYKAFGLV | 131 | Q96QD8 | |
| LGAGQLSLYNILKAY | 866 | Q86TI0 | |
| YLGANSVVYLSVEGL | 451 | Q06203 | |
| GLYTIYLNGDKAEAL | 1996 | P24821 | |
| GKVSQYTGRAVLYVL | 311 | Q86WB7 | |
| DGYLLLKSVYVLTGT | 136 | Q6ZS81 | |
| VNGYSYKVAVALSLF | 116 | Q9BX74 | |
| YNSAGLLIKAYNRAG | 2271 | Q6N022 | |
| VLNYLKTSGEYKLAG | 81 | Q5JUR7 | |
| KTVSGTALYYAGLFL | 106 | Q8NDW8 | |
| TYAKLGGLYTQSLAR | 951 | Q86YV5 | |
| LLKYITGDNLVKGSY | 66 | A0A0B4J244 | |
| LLLAGKIQFGYVYGI | 141 | Q969M3 | |
| GKSYSVALYLVRQLT | 266 | Q8N2W9 | |
| KGYLALGLTYSLQAT | 471 | Q86TV6 | |
| IQGFLYAYSISTIIK | 441 | Q2M389 | |
| YDAGLLLVVKASYGT | 36 | Q9BY10 | |
| LLDNSGGVIYAYKAL | 141 | Q9P0Z9 | |
| RAYGYSGVSLKVVNS | 1056 | P35442 | |
| LEGASKGISYYIGAQ | 286 | Q9UN76 | |
| LSAALYYLVVQGKKG | 96 | P56192 | |
| LYLIYSQVLFKGQGC | 131 | P01375 | |
| GAALQLAISTYAAYI | 81 | Q96IK0 | |
| VITTVYGYKVQLQAG | 2391 | Q9Y493 | |
| VKAYGAGLLSSYGEL | 416 | P07101 | |
| YQKESQVYLLGTGLR | 476 | Q13094 | |
| LTQNTLGYEGIVKLY | 1021 | Q86W24 | |
| TIGYLLTRYAESLGQ | 541 | Q14CX7 | |
| AGKYRITNNYGLLSL | 201 | Q5VTT5 | |
| VYLAAGTVYGLETQL | 701 | Q8NFW9 |